LaD Receipt: 09/10/2014 23:00:00 -Results: 09/13/2014 16:13:00 Electronically signed off by 09/14/2014 TEST DESCRIPTION OUT -OF-RANGE Result Status Key: X - Test canceled or cannot be obtained IN-RANGE UNITS EXPECTED The percent (%) differential reference intervals for normal cell types will be removed from patient reports beginning september 15, 2014, consistent with ~p standards. Immature Grans (Abs): 0.0 x10E3/UL NRBC: (x) Hematology Comments:: (X) 0.0-0.1 322000 - Compo Metabolic Panel (14) Glucose, Serum: BUN: creatinine, Serum: eGFR If NonAfricn Am: eGFR If Africn Am: BUN/creatinine Ratio: sodium, Serum: Potassium, Serum: chloride, Serum: carbon Dioxide, Total: calcium, Serum: Protein, Total, Serum: Albumin, Serum: Globulin, Total: A/G Ratio: Bilirubin, Total: Alkaline phosphatase, s: AST (SGOT): ALT (SGPT): 1.32 96 1.4 ~ 92 mg/dL 65-99 21 mg/dL 6-24 mg/dL 0.76-1.27 62 mL/min/1.73 >59 71 mL/min/1.73 >59 16 9-20 134 mmol/L 134-144 5.2 mmol/L 3.5-5.2 mmol/L 97-108 26 mmol/L 18-29 9.2 mg/dl 8.7-10.2 7.4 g/dL 6.0-8.5 5.1 g/dL 3.5-5.5 2.3 g/dL 1.5-4.5 2.2 1.1-2.5 mg/dL 0.0-1.2 87 IU/L 39-117 22 lull 0-40 25 IU/L 0-44 505005 - Helper Suppressor Short Prof. Absolute CD 3: Absolute CD 4 Helper: Abs. CD 8 Suppressor: % CD 3 POSe lymph.: % CD 4 POSe lymph.: % CD 8 POSe Lymph.: CD4/CD8 Ratio: 1556 /Ul 622-2402 768 /UL 359-1519 776 /Ul 109-897 77.8 % 57.5-86.2 38.4 % 30.8-58.5 38.8 % 12.0-35.5 0.99 0.92-3.72 303756 - Lipid Panel Cholesterol, Total: 182 mg/dl 100-199
Collection: 09/10/2014 09:01 :00 16:13:00 Lab Receipt: 09/10/201423:00:00 - -.........- Results: 09/13/2014 •••••• n 09/14/2014 TEST DESCRIPTION OUT -OF-RANGE IN-RANGE UNITS EXPECTED X10E3/UL 1.4-7.0 X10E3/UL 0.7-3.1 x10E3/UL 0.1-0.9 X10E3/UL 0.0-0.4 X10E3/UL 0.0-0.2 % 0-2 Result Status Key: X - Test canceled or cannot be obtained Patient is Fasting 5009 - CBC With Differential/Platelet WBC: RBC: Hemoglobin: Hematocrit: MCV: MCH: MCHC: ROW: Platelets: Neutrophils: 37 % The percent (%) differential reference intervals for normal cell types will be removed from patient reports beginning september 15, 2014, consistent with ~p standards. Lymphs: 50 % The percent (%) di fferenti a 1 reference interva 1s for norma1 ce 11 types will be removed from patient reports beginning september 15, 2014, consistent with ~p standards. Monocytes: 10 % The percent (%) di fferenti a 1 reference interva 1 s for norma1 ce 11 types wi 11 be removed from patient reports beginning September 15, 2014, consistent with ~p standards. Eos: 2 % The percent (%) differential reference intervals for normal cell types wi 11 be removed from patient reports beginning September 15, 2014, consistent with ~p standards. Basos: 1 % The percent (%) differential reference intervals for normal cell types will be removed from patient reports beginning September 15, 2014, consistent with ~p standards. Immature Cells: (x) Neutrophils (Absolute): 1.5 Lymphs (Absolute): 2.0 Monocytes(Absolute): 0.4 Eos (Absolute): 0.1 4.0 x10E3/UL 4.68 x10E6/UL 15.1 g/dL 45.1 % 96 fL 32.3 pg 33.5 g/dL 12.9 % 183 Xl0E3/UL Baso (Absolute): Immature Granulocytes: 0.0 o 3.4-10.8 4.14-5.80 12.6-17.7 37.5-51.0 79-97 26.6-33.0 31.5-35.? 12.3-15.4 150-379 40-74 14-46 4-12 0-5 0-3
""UIIC\o.UUII;lun~/LU14 u~:uu:uu 07:16:00 't 'It! Lab Receipt: 10/14/201421 :08:00 Results: 10/15/2014 Electronically signed off by TEST DESCRIPTION OUT -OF-RANGE IN-RANGE UNITS EXPECTED Result Status Key: X - Test canceled or cannot be obtained 3038 - Urinalysis, Routine Specific Gravity: 1.017 pH: 6.0 urine-color: Yellow Appearance: clear WBC Esterase: Negative Protein: Trace Glucose: Negative Glucose Reflex: (x) Ketones: Negative occult Blood: Trace Bi 1 i rubi n: Negative urobilinogen,semi-Qn: 0.2 1.005-1.030 5.0-7.5 Yellow clear Negative Negative/Trace Negative mg/dL Negative Negative Negative 0.0-1.9 Negative Nitrite, urine: Microscopic Examination: Negative See below: Microscopic was indicated and was performed. 333328 - Microscopic Examination (auto-generated/reflex) Parent Result: 012237 WBC: RBC: Epithelial cells (non renal): Epithelial cells (renal): 0-5 0-2 /hpf /hpf /hpf 0-5 0-2 o - 10 None seen (x) (x) (x) (X) (x) Casts: Cast Type: Crystal s: crystal Type: Mucus Threads: Bacteria: Yeast: Trichomonas: Comment: Present None seen Not Estab. None seen/Few (x) (x) (x) 10322 - Prostate-Specific Ag, Serum Prostate Specific Ag, Serum: Roche ECLIA methodo7ogy. 0.0-4.0 1.0 ng/mL According to the American Urologica7 Association, Serum PSA shou7d
11/0212014 COllectiOn: [REDACTED_ID] 08:50:00 20:07:00 Lab YReceipt: 10/28/2014 21 :07:00 Results: 11/0212014 TEST DESCRIPTION OUY..oF-RANGE IN-RANGE UNITS EXPECTED 1321 -Iron and TI8e Iron Bind.cap ..(TDC): UIBC: Iron J seru ••: Iron Saturation: 318 228 90 28 ug/dL ug/dL ug/dL % 250-450 150-375 40-155 15-55 1974 - Thyroxine (T4) Free, Direct, S T4,Free(Direct): 1.09 ng/dl 0.82-1.77 4051 .•Cortisol cortisol: 23.4 cortiso1 AM cortisol PM ug/dL 6.2 - 19.4 2.3 - 11.9 2.3-19.4 Iu/ml ortion of the 0.0-0.9 6692 - AntithyroglobuJin Ab Thyroglobulin, Antibody: Lowpositive Thyroglobulin anti asympt:omatic popu7ations. Anrithyroglobu1in antibodies measured by Beckman coulter Methodology 70104 - Reverse T3, Serum Reverse T3, Serum: 19.3 ng/dl 9.2-24.1 10389 - Triiodothyronine,Free,Serum Triiodothyronine,Free, Serum: ng/mL 30-400 4598 • Ferritin,Serum Ferritin, Serum: 6676 - Thyroid Peroxidase (TPO) Ab Thy~id Peroxidase (TPO) Ab: IU/ml 0-34 2.6 pg/mL 2.0-4.4 Performing laboratory: labCorp Houston. 7207 North Gessner&&Houston&TX&770403143# 01 Performing laboratory: labCorp Burlington, 1447 York Court&&Burlington8NC&212153361# 02
\,;Ollectlon: 10/14/2014 08:12:00 Lab Receipt: 10/14/2014 20:48:00 - on 10/16/2014 Results: 10/16/2014 08:27:00 Electronically signed off by / TEST DESCRIPTION OUT -OF-RANGE IN-RANGE Result Status Key: X - Test canceled or cannot be obtained Patient is Fasting UNITS EXPECTED Testosterone, Serum: Comment: : Adu7t ma7e reference interval is based on a population of 7ean ma7es up to 40 years o7d. 381128 - Uric A+TSH+TestT+ApoIiB uric Acid, Serum: 4.9 mgjdL <6.0 mgjdL uIUjmL 3.7-8.6 0-79 0.450-4.500 Apolipoprotein B: TSH: Comment: : Therapeutic target 83 for gout patients: ~ 533 ngjdL 348-1197 Performing Laboratory: LabCorp Houston, 7207 North Gessner&&Houston&TX&770403143# 01 Performing Laboratory: LabCorp Burlington, 1447 York Court&&Burlington&NC&272153361# 02
